{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:04:55Z","timestamp":1774541095040,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010682","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T00:00:00Z","timestamp":1417564800000}}],"reference-count":58,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010682.pub2","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T23:10:28Z","timestamp":1417561828000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antidepressants for people with epilepsy and depression"],"prefix":"10.1002","author":[{"given":"Melissa J","family":"Maguire","sequence":"first","affiliation":[{"name":"Leeds General Infirmary; Department of Neurology; Great George Street Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Weston","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Fazakerley Liverpool Merseyside UK L9 7LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasvinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Humber NHS Foundation Trust; Department of Psychological Medicine; 220-236 Anlaby Road Hull UK HU3 2RT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Fazakerley Liverpool Merseyside UK L9 7LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"key":"10.1002\/14651858.CD010682.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/ebeh.2000.0123","article-title":"Treatment of interictal depression with citalopram in patients with epilepsy","volume":"1","author":"Hovorka","year":"2000","journal-title":"Epilepsy and Behavior"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/ebeh.2000.0050","article-title":"The use of sertraline in patients with epilepsy: is it safe?","volume":"1","author":"Kanner","year":"2000","journal-title":"Epilepsy and Behavior"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2003.08.009","article-title":"Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants","volume":"4","author":"Kuhn","year":"2003","journal-title":"Epilepsy and Behavior"},{"issue":"12","key":"10.1002\/14651858.CD010682.pub2-BIB0004|cit4","first-page":"20","article-title":"A randomized controlled trial to evaluate the efficacy of paroxetine and doxepin in treating epileptic patients with depression","volume":"9","author":"Li","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-0327(85)90091-6","article-title":"The treatment of depression in patients with epilepsy: a double blind trial","volume":"9","author":"Robertson","year":"1985","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD010682.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002826-200405000-00009","article-title":"Citalopram as treatment of depression in patients with epilepsy","volume":"27","author":"Specchio","year":"2004","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yebeh.2007.01.004","article-title":"Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression","volume":"10","author":"Thome-Souza","year":"2007","journal-title":"Epilepsy and Behavior"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0008|cit8","first-page":"101","article-title":"Short-term efficacy of venlafaxine treating the depression in epilepsy patients","volume":"19","author":"Zhu","year":"2004","journal-title":"Chinese Journal of Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD010682.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.v58n0101","article-title":"Antidepressant and double antidepressant treatment for the affective disorder of epilepsy","volume":"58","author":"Blumer","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0010|cit10","unstructured":"Gilliam F Depression and health outcomes in refractory epilepsy www.clinicaltrials.gov\/ct\/show\/NCT00026637 2005"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0011|cit11","unstructured":"Kocsis Lexapro for major depression in patients with epilepsy www.clinicaltrials.gov\/ct\/show\/NCT01244724 2007"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0012|cit12","unstructured":"Conrad E Escitalopram treatment of major depression in patients with temporal lobe epilepsy www.clinicaltrials.gov\/ct\/show\/NCT00595699 2008"},{"issue":"8711","key":"10.1002\/14651858.CD010682.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0140-6736(90)91938-7","article-title":"Fluvoxamine: an antidepressant with low (or no) epileptogenic effect","volume":"336","author":"Harmant","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yebeh.2010.06.045","article-title":"Cholesterol concentrations and clinical response to sertraline in patients with epilepsy: preliminary results","volume":"19","author":"Machado","year":"2010","journal-title":"Epilepsy & Behavior"},{"issue":"6","key":"10.1002\/14651858.CD010682.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.bp.107.046664","article-title":"Neuropsychiatric morbidity in focal epilepsy","volume":"192","author":"Adams","year":"2008","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD010682.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0017|cit17","volume-title":"Diagnostic and Statistical Manual","author":"American Psychiatric Association","year":"2000"},{"issue":"12","key":"10.1002\/14651858.CD010682.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1499-1654.2000.001608.x","article-title":"Psychiatric outcome after temporal lobectomy: a predictive study","volume":"41","author":"Anhoury","year":"2000","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD010682.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0920-1211(96)00017-4","article-title":"The associations of psychopathology in epilepsy: a community study","volume":"25","author":"Baker","year":"1996","journal-title":"Epilepsy Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010682.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.yebeh.2008.04.005","article-title":"Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders","volume":"13","author":"Barry","year":"2008","journal-title":"Epilepsy & Behavior"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010682.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.yebeh.2010.08.018","article-title":"Depression in epilepsy: why aren't we treating?","volume":"19","author":"Cotterman-Hart","year":"2010","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0025|cit25","unstructured":"Dell'osso MC Caserta A Baroni S Nisita C Marazziti D The relationship between epilepsy and depression: an update Current Medicinal Chemistry"},{"issue":"6","key":"10.1002\/14651858.CD010682.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1212\/WNL.0b013e31827b1ae0","article-title":"Depression in epilepsy: a systematic review and meta-analysis","volume":"80","author":"Fiest","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.wco.0000162853.29650.ec","article-title":"Diagnosis and treatment of mood disorders in persons with epilepsy","volume":"18","author":"Gilliam","year":"2005","journal-title":"Current Opinion in Neurology"},{"issue":"7650","key":"10.1002\/14651858.CD010682.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD010682.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yebeh.2012.10.009","article-title":"Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?","volume":"26","author":"Hamid","year":"2013","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1111\/j.1528-1157.2000.tb01522.x","article-title":"Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression","volume":"41 Suppl 2","author":"Hermann","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E","article-title":"Major depression is a risk factor for seizures in older adults","volume":"47","author":"Hesdorffer","year":"2000","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010682.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.20685","article-title":"Depression and suicide attempt as risk factors for incident unprovoked seizures","volume":"59","author":"Hesdorffer","year":"2006","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010682.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","article-title":"The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: a bidirectional association","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0035|cit35","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2-3","key":"10.1002\/14651858.CD010682.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0920-1211(92)90090-G","article-title":"Interictal depression in epilepsy","volume":"12","author":"Indaco","year":"1992","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1528-1157.1996.tb00006.x","article-title":"The clinical course of epilepsy and its psychological correlates: finding from a U.K. community study","volume":"37","author":"Jacoby","year":"1996","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD010682.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5698\/1535-7511-11.5.149","article-title":"Hippocampal atrophy: another common pathogenic mechanism of depressive disorders and epilepsy?","volume":"11","author":"Kanner","year":"2011","journal-title":"Epilepsy Currents"},{"issue":"11","key":"10.1002\/14651858.CD010682.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1528-1167.2011.03276.x","article-title":"International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy","volume":"52","author":"Kerr","year":"2011","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD010682.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.1990.01810240078012","article-title":"Treatment of recurrent unipolar major depressive disorder. Commentary on the Pittsburgh study","volume":"47","author":"Klerman","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0404.2008.01088.x","article-title":"Don't be afraid to treat depression in patients with epilepsy!","volume":"119","author":"Kondziella","year":"2009","journal-title":"Acta Neurologica Scandinavica"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD010682.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"s21","DOI":"10.1111\/j.1528-1157.1999.tb00884.x","article-title":"Depression in epilepsy: etiology, phenomenology, and treatment","volume":"40","author":"Lambert","year":"1999","journal-title":"Epilepsia"},{"issue":"9848","key":"10.1002\/14651858.CD010682.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","article-title":"Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan","volume":"380","author":"Lin","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2008.03.024","article-title":"Overwhelming heterogeneity in systematic reviews of observational anti-epileptic studies","volume":"80","author":"Maguire","year":"2008","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD010682.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archneur.1986.00520080014012","article-title":"Depression in epilepsy: significance and phenomenology","volume":"43","author":"Mendez","year":"1986","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010682.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1756285609337340","article-title":"Depression in epilepsy: mechanisms and therapeutic approach","volume":"2","author":"Mula","year":"2009","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"1","key":"10.1002\/14651858.CD010682.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1528-1167.2012.03688.x","article-title":"Antiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology","volume":"54","author":"Mula","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD010682.pub2-BIB0050|cit50","first-page":"160","article-title":"Tricyclic antidepressant-induced seizures and plasma drug concentration","volume":"53","author":"Preskorn","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD010682.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.biopsych.2005.08.033","article-title":"Determining the duration of antidepressant treatment: application of signal detection methodology and the need for duration adaptive designs (DAD)","volume":"59","author":"Sackeim","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD010682.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4088\/JCP.v61n0302","article-title":"Blue genes and the mechanism of action of antidepressants","volume":"61","author":"Stahl","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD010682.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD010682.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2011.03213.x","article-title":"Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review","volume":"52","author":"Taylor","year":"2011","journal-title":"Epilepsia"},{"issue":"12","key":"10.1002\/14651858.CD010682.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD010682.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000026531","article-title":"New antiepileptic drugs and psychopathology","volume":"38","author":"Trimble","year":"1998","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1002\/14651858.CD010682.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00004714-199004000-00009","article-title":"The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population","volume":"10","author":"Wroblewski","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD010682.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010682.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010682.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:08:57Z","timestamp":1717600137000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010682.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,3]]},"references-count":58,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010682.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD010682.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,3]]}}}